By Kathryn Hardison
Johnson & Johnson's Kenvue Inc., which will be its stand-alone company for consumer health brands, has filed for an initial public offering.
The offering is part of Kenvue's previously disclosed separation from Johnson & Johnson, which will continue to be the name of the company housing its prescription-drug and medical-devices units. Kenvue will oversee brands such as Band-Aid and Tylenol.
Kenvue has filed for an initial public offering with the Securities and Exchange Commission, though it didn't disclose the financial details of the planned offering in a Wednesday filing.
The company said that all of the net proceeds from the sale of shares in the offering will be paid to Johnson & Johnson.
Kenvue will apply to list its shares under the ticker KVUE.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
01-04-23 1719ET